Maria L. Iaia

Tricase, 73039, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancer.

CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancer.

Journal: BMC cancer
Published: April 11, 2025

Immunotherapy and Pancreatic Cancer: A Lost Challenge?

Immunotherapy and Pancreatic Cancer: A Lost Challenge?

Journal: Life (Basel, Switzerland)
Published: June 07, 2023

The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies.

The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies.

Journal: Pharmaceutics
Published: April 21, 2023

Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives.

Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives.

Journal: Current oncology (Toronto, Ont.)
Published: April 18, 2023

Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?

Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?

Journal: Expert opinion on pharmacotherapy
Published: April 11, 2023

Reliability of patient-reported toxicities during adjuvant chemotherapy.

Reliability of patient-reported toxicities during adjuvant chemotherapy.

Journal: European journal of cancer (Oxford, England : 1990)
Published: November 23, 2022

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.

Journal: Cancers
Published: August 08, 2022

Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients.

Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients.

Journal: International journal of molecular sciences
Published: March 21, 2022

Tailoring antiHer2 treatment strategies in breast cancer and beyond.

Tailoring antiHer2 treatment strategies in breast cancer and beyond.

Journal: Current problems in cancer
Published: February 22, 2022

An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA.

An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA.

Journal: Expert review of molecular diagnostics
Published: May 27, 2021

Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy.

Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy.

Journal: Cancers
Published: January 28, 2021

Germline BRCA-mutated metastatic breast cancer with positive hormone receptor.

Germline BRCA-mutated metastatic breast cancer with positive hormone receptor.

Journal: Breast cancer research and treatment
Published: October 16, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026